Abstract
PCN115 - Cost-Utility Analysis of Erlotib Versus Standard Chemotherapy in First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in Vietnam
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have